TY  - JOUR
AU  - Yubero-Serrano, Elena M
AU  - Alcala-Diaz, Juan F
AU  - Gutierrez-Mariscal, Francisco M
AU  - Arenas-de Larriva, Antonio P
AU  - Peña-Orihuela, Patricia J
AU  - Blanco-Rojo, Ruth
AU  - Martinez-Botas, Javier
AU  - Torres-Peña, Jose D
AU  - Perez-Martinez, Pablo
AU  - Ordovas, Jose M
AU  - Delgado-Lista, Javier
AU  - Gomez-Coronado, Diego
AU  - Lopez-Miranda, Jose
PY  - 2021
DO  - 10.1186/s12933-021-01260-3
UR  - http://hdl.handle.net/10668/17403
T2  - Cardiovascular diabetology
AB  - Peripheral artery disease (PAD) is recognized as a significant predictor of mortality and adverse cardiovascular outcomes in patients with coronary heart disease (CHD). In fact, coexisting PAD and CHD is strongly associated with a greater coronary...
LA  - en
PB  - BioMed Central
KW  - Cholesterol efflux capacity
KW  - Coronary heart disease
KW  - Peripheral artery disease
KW  - Secondary prevention
KW  - Type 2 diabetes mellitus
KW  - Adult
KW  - Aged
KW  - Apolipoprotein B-100
KW  - Biomarkers
KW  - Cholesterol
KW  - Coronary disease
KW  - Cross-sectional studies
KW  - Diabetes mellitus, type 2
KW  - Female
KW  - Humans
KW  - Macrophages
KW  - Male
KW  - Middle aged
KW  - Peripheral arterial disease
KW  - Randomized controlled trials as topic
KW  - Spain
KW  - THP-1 cells
KW  - Young adult
TI  - Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
TY  - research article
VL  - 20
ER  -